Spots Global Cancer Trial Database for Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
Official Title: A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Program and Traditional In-person Genetic Counseling in Women Newly Diagnosed With Breast Cancer Who do Not Currently Meet National Comprehensive Cancer Network (NCCN) Criteria for Genetic Testing.
Study ID: NCT04354675
Conditions
Study Description
Brief Summary: The purpose of this study is to help better understand the uptake and impact of genetic testing for women diagnosed with breast cancer who do not meet National Comprehensive Cancer Network (NCCN) criteria for genetic testing. By doing so, the research team will gain a better understanding of the clinical implications for offering genetic testing for all patients recently diagnosed with breast cancer versus only offering genetic testing to those meeting NCCN criteria. By offering genetic counseling and genetic testing to all women recently diagnosed with breast cancer, there will be a shortage of genetic counselors. This study will also assess the feasibility of using artificial intelligence to assist in the genetic counseling process.
Detailed Description: This is a randomized trial comparing the effectiveness of pre-test genetic counseling using an artificial intelligence program and traditional in-person genetic counseling in women newly diagnosed with breast cancer who do not currently meet National Comprehensive Cancer Network (NCCN) criteria for genetic testing. The primary objectives of this study are: 1. To determine up-take of testing for those who do not meet NCCN guidelines for genetic testing 2. To assess overall patient satisfaction and comprehension in both groups The secondary objectives of this study are: 1. To assess mutation rate in the overall cohort 2. Identify reasons for not pursuing genetic testing 3. Identify any specific areas of improvement in satisfaction and comprehension 4. Assess the impact of genetic testing on Time to Treatment in this cohort 5. Develop workflow for offering genetic testing, providing pre-test genetic counseling, ordering testing, and delivering results
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Contact Details
Name: Zahraa Al-Hilli, MD
Affiliation: Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
